医学信息
醫學信息
의학신식
MEDICAL INFORMATION
2014年
19期
131-132
,共2页
慢性心力衰竭%黄芪扶正颗粒%BNP
慢性心力衰竭%黃芪扶正顆粒%BNP
만성심력쇠갈%황기부정과립%BNP
Chronic heart failure%Astragalus righting particles%BNP
目的探讨黄芪扶正颗粒治疗心力衰竭的临床疗效。方法收集60例慢性心力衰竭患者临床资料,随机分为两组,各30例。对照组给予抗心衰基础治疗,治疗组加用黄芪扶正颗粒。对比两组患者治疗总有效率、心室功能、BNP水平以及不良反应发生情况。结果治疗组总有效率显著高于对照组(P<0.05);治疗后,治疗组左心室射血分数、心输出量、E/A与治疗前和对照组相比,均有显著性差异(P<0.01,P<0.05);治疗后,两组患者BNP水平均有显著改善,但是治疗组程度较对照组显著(P<0.05)。观察组对美托洛尔、卡托普利的耐受剂量显著高于对照组(P<0.05)。结论黄芪扶正颗粒治疗慢性心力衰竭安全有效,能够改善患者左心室功能,提高机体对美托洛尔、卡托普利的耐受剂量,利于BNP水平恢复。
目的探討黃芪扶正顆粒治療心力衰竭的臨床療效。方法收集60例慢性心力衰竭患者臨床資料,隨機分為兩組,各30例。對照組給予抗心衰基礎治療,治療組加用黃芪扶正顆粒。對比兩組患者治療總有效率、心室功能、BNP水平以及不良反應髮生情況。結果治療組總有效率顯著高于對照組(P<0.05);治療後,治療組左心室射血分數、心輸齣量、E/A與治療前和對照組相比,均有顯著性差異(P<0.01,P<0.05);治療後,兩組患者BNP水平均有顯著改善,但是治療組程度較對照組顯著(P<0.05)。觀察組對美託洛爾、卡託普利的耐受劑量顯著高于對照組(P<0.05)。結論黃芪扶正顆粒治療慢性心力衰竭安全有效,能夠改善患者左心室功能,提高機體對美託洛爾、卡託普利的耐受劑量,利于BNP水平恢複。
목적탐토황기부정과립치료심력쇠갈적림상료효。방법수집60례만성심력쇠갈환자림상자료,수궤분위량조,각30례。대조조급여항심쇠기출치료,치료조가용황기부정과립。대비량조환자치료총유효솔、심실공능、BNP수평이급불량반응발생정황。결과치료조총유효솔현저고우대조조(P<0.05);치료후,치료조좌심실사혈분수、심수출량、E/A여치료전화대조조상비,균유현저성차이(P<0.01,P<0.05);치료후,량조환자BNP수평균유현저개선,단시치료조정도교대조조현저(P<0.05)。관찰조대미탁락이、잡탁보리적내수제량현저고우대조조(P<0.05)。결론황기부정과립치료만성심력쇠갈안전유효,능구개선환자좌심실공능,제고궤체대미탁락이、잡탁보리적내수제량,리우BNP수평회복。
Objective To investigate the clinical ef icacy of treatment of heart failure Astragalus righting particles . Methods The clinical data of patients with chronic heart failure, 60 patients were randomly divided into two groups , each of 30 cases . The control group received basic anti-heart failure treatment , the treatment group Astragalus righting particles. Contrast the treatment of patients with total ef ective rate , ventricular function , BNP levels and adverse events . Results The total ef ective rate was significantly higher ( <0.05); After treatment, the treatment group, left ventricular ejection fraction , cardiac output, front E / A treatment compared with the control group , there were significant dif erences ( <0.01, <0.05); after treatment , BNP levels were significantly improved in both groups , but the extent of the treatment group compared with the control group was significantly ( <0.05). Tolerated dose group for observation metoprolol, captopril significantly higher for the control group ( <0.05). Conclusion Astragalus righting particles safe and ef ective treatment of chronic heart failure can improve left ventricular function, improve the body's tolerance dose of metoprolol , captopril , BNP levels conducive to recovery .